Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells-Reference-Cited by-同舟云学术

Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells

Published:2022-01-14 Issue:9 Volume:43 Page:2419-2428
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Shu Changfa,Zheng Xi,Wuhafu Alafate,Cicka Danielle,Doyle Sean,Niu Qiankun,Fan Dacheng,Qian Kun,Ivanov Andrey A.,Du Yuhong,Mo Xiulei,Fu Haian

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-021-00847-6.pdf

Reference57 articles.

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7–33.

2. Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69:280–304.

3. Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi24–32.

4. Mikula-Pietrasik J, Witucka A, Pakula M, Uruski P, Begier-Krasinska B, Niklas A, et al. Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells. Cell Mol Life Sci. 2019;76:681–97.

5. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med. 1996;334:1–6.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway;Cancer Management and Research;2024-05

2. Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes;Frontiers in Oncology;2023-05-15

3. ACSM3 suppresses proliferation and induces apoptosis and cell cycle arrest in acute myeloid leukemia cells via the regulation of IGF2BP2;Experimental and Therapeutic Medicine;2023-03-08

4. p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons;Diagnostics;2022-12-05

5. A p53 transcriptional signature in primary and metastatic cancers derived using machine learning;Frontiers in Genetics;2022-08-29